Angiodynamics (ANGO) Other Non-Current Liabilities (2012 - 2026)

Angiodynamics has reported Other Non-Current Liabilities for 15 years, with the latest figure at $16.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 3.86% year-over-year to $16.7 million; the trailing twelve-month figure through Feb 2026 stood at $16.7 million (down 3.86% YoY), and the FY2025 full-year result was $16.9 million, up 5.14% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $16.7 million, down from $17.1 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $17.4 million in Q1 2025, with the low at $3.0 million in Q3 2023.
• Historically, Other Non-Current Liabilities has averaged $10.7 million across 5 years, with a median of $13.0 million in 2024.
• Annual changes were most pronounced in 2022 — Other Non-Current Liabilities plunged 78.69% — and 2024, when it soared 428.26%.
• Angiodynamics' Other Non-Current Liabilities stood at $3.5 million in 2022, then slipped by 15.55% to $3.0 million in 2023, then jumped by 298.29% to $11.9 million in 2024, then surged by 43.88% to $17.1 million in 2025, then dropped by 2.07% to $16.7 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $16.7 million (Q1 2026), $17.1 million (Q4 2025), and $14.2 million (Q3 2025), per Business Quant data.